Data-driven financial and biotechnology company, specialized in quantitative assessment of human biomarkers, development of biomarker panels and biological age metrics, their application for investment de-risking, insurance and hedging objectives, development of structured financial products and analytics linked to human biomarkers and biological age.

The main goal of the company is to introduce biomarker-driven Longevity risks mitigation for a broad group of financial and healthcare-related entities. Founded in November 2021, with headquarters in Basel, Switzerland and branches in the United Kingdom, Germany and Ukraine.